Back to search

46 Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES)

Data up to Jan 2025

Published2004
Citations37
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
46 Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in… (2004) – Journal of Hepatology | Metascience Observatory Explorer